Clinical Trial

Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)

Name: Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM) — clinical trial record (NCT06462664)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EMYNEM

Recruiting

View on ClinicalTrials.gov →

Summary

Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro

Trial Details

NCT Number	NCT06462664
Lead Sponsor	University Hospital, Brest
Conditions	Myeloproliferative Neoplasm
Enrollment	10 participants
Start Date	2024-06-01
Primary Completion	2028-01-31 (estimated)
Study Completion	2028-01-31 (estimated)
Updated on ClinicalTrials.gov	2024-06-17